[New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects].
Romero Gómez
M
M
Unidad de Hepatología, Hospital Universitario de Valme, Ctra. Cádiz, s/n, 41014 Sevilla, España. mromerog@supercable.es
Bautista
J D
JD
Grande
L
L
Ramos Guerrero
R M
RM
Sánchez Muñoz
D
D
D000641:Ammonia / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D001929:Brain Edema / Q000209:etiology / Q000503:physiopathology; D004151:Dipeptides / Q000627:therapeutic use; D005442:Flumazenil / Q000627:therapeutic use; D005972:Glutaminase / Q000737:chemistry / Q000378:metabolism; D005973:Glutamine / Q000378:metabolism; D006501:Hepatic Encephalopathy / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D006801:Humans; D022124:Hyperammonemia / Q000150:complications; D007249:Inflammation; D007421:Intestine, Small / Q000503:physiopathology; D007668:Kidney / Q000503:physiopathology; D008559:Memantine / Q000627:therapeutic use; D008958:Models, Molecular; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D009569:Nitric Oxide / Q000378:metabolism
D004151:Dipeptides; D009419:Nerve Tissue Proteins; D005973:Glutamine; D009569:Nitric Oxide; D005442:Flumazenil; D000641:Ammonia; D005972:Glutaminase; C002939:ornithylaspartate; D008559:Memantine